Furthermore, Lachnospiraceae were detected in both donors and recipient responder patients52 of the two clinical trials that demonstrated that combining FMT from ICI responders with anti-PD-1 therapy can overcome resistance to PD-1 blockade in refractory melanoma patients. The gene discussed is PDCD1; the disease is melanoma.